Adjunctive corticosteroids not superior to placebo, while adjunctive corneal cross-linking associated with increased scar size
Read More »Antiseizure Meds With Known or Uncertain Risks Continue to Be Prescribed in Pregnancy
However, safer antiseizure medications are gaining favor
Read More »Remote CBT-Based Therapy Yields Modest Improvements in Chronic Pain
Both telehealth and self-completed online intervention groups more likely to attain clinically important difference in pain severity versus usual care
Read More »Glipizide Linked to Highest MACE-4 Risk in Individuals With Type 2 Diabetes
Highest risk seen with glipizide versus other sulfonylureas and DPP4 inhibitors as second-line therapy
Read More »Physical Activity Steadily Declines From Young Adulthood to Middle Age
MVPA begins declining about 12 years before cardiovascular disease, with accelerated declines within two years of event
Read More »Novel Treatments Recommended for Management of Atopic Dermatitis in Adults
Strong recommendations presented for tapinarof cream, roflumilast cream, lebrikizumab, nemolizumab with concomitant topical therapy
Read More »Patients Face High Out-of-Pocket Costs After Incident Cancer Diagnosis
Cost increased monotonically with stage at diagnosis, from $462.01 per month for stage 0 to $719.97 per month for stage 4
Read More »Exposure to PFAS Mixtures Linked to Increased Odds of Type 2 Diabetes
Odds of incident T2D increased in association with each tertile increase in the PFAS mixture
Read More »Rebound Weight Gain Common After Discontinuing Antiobesity Medications
AOMs linked to significant weight regain at eight weeks after drug discontinuation compared with control group
Read More »Wheat, Gluten May Be Safe to Consume for Many With IBS and Self-Perceived Sensitivity
Patients with self-perceived gluten sensitivity reacted similarly to wheat, gluten, and sham challenges
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.